These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18210954)

  • 1. Phase I trial on the safety of topical rhVEGF on chronic neuropathic diabetic foot ulcers.
    Hanft JR; Pollak RA; Barbul A; van Gils C; Kwon PS; Gray SM; Lynch CJ; Semba CP; Breen TJ
    J Wound Care; 2008 Jan; 17(1):30-2, 34-7. PubMed ID: 18210954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of topical phenytoin on recalcitrant neuropathic diabetic foot ulceration.
    El-Nahas M; Gawish H; Tarshoby M; State O
    J Wound Care; 2009 Jan; 18(1):33-7. PubMed ID: 19131916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of topical basic fibroblast growth factor on the healing of chronic diabetic neuropathic ulcer of the foot. A pilot, randomized, double-blind, placebo-controlled study.
    Richard JL; Parer-Richard C; Daures JP; Clouet S; Vannereau D; Bringer J; Rodier M; Jacob C; Comte-Bardonnet M
    Diabetes Care; 1995 Jan; 18(1):64-9. PubMed ID: 7698050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of short-contact topical tretinoin therapy for foot ulcers in patients with diabetes.
    Tom WL; Peng DH; Allaei A; Hsu D; Hata TR
    Arch Dermatol; 2005 Nov; 141(11):1373-7. PubMed ID: 16301384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and microbiological efficacy of MDT in the treatment of diabetic foot ulcers.
    Tantawi TI; Gohar YM; Kotb MM; Beshara FM; El-Naggar MM
    J Wound Care; 2007 Oct; 16(9):379-83. PubMed ID: 17987750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a topical gel formulation of recombinant human platelet-derived growth factor-BB (becaplermin) in patients with chronic neuropathic diabetic ulcers. A phase III randomized placebo-controlled double-blind study.
    Wieman TJ; Smiell JM; Su Y
    Diabetes Care; 1998 May; 21(5):822-7. PubMed ID: 9589248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial.
    Ma C; Hernandez MA; Kirkpatrick VE; Liang LJ; Nouvong AL; Gordon II
    Wounds; 2015 Apr; 27(4):83-91. PubMed ID: 25855851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Talactoferrin alfa, a recombinant human lactoferrin promotes healing of diabetic neuropathic ulcers: a phase 1/2 clinical study.
    Lyons TE; Miller MS; Serena T; Sheehan P; Lavery L; Kirsner RS; Armstrong DG; Reese A; Yankee EW; Veves A
    Am J Surg; 2007 Jan; 193(1):49-54. PubMed ID: 17188087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical epidermal growth factor spray for the treatment of chronic diabetic foot ulcers: A phase III multicenter, double-blind, randomized, placebo-controlled trial.
    Park KH; Han SH; Hong JP; Han SK; Lee DH; Kim BS; Ahn JH; Lee JW
    Diabetes Res Clin Pract; 2018 Aug; 142():335-344. PubMed ID: 29902542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photodynamic topical antimicrobial therapy for infected foot ulcers in patients with diabetes: a randomized, double-blind, placebo-controlled study--the D.A.N.T.E (Diabetic ulcer Antimicrobial New Topical treatment Evaluation) study.
    Mannucci E; Genovese S; Monami M; Navalesi G; Dotta F; Anichini R; Romagnoli F; Gensini G
    Acta Diabetol; 2014; 51(3):435-40. PubMed ID: 24352342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of PDRN, an adenosine receptor A2A agonist, on the healing of chronic diabetic foot ulcers: results of a clinical trial.
    Squadrito F; Bitto A; Altavilla D; Arcoraci V; De Caridi G; De Feo ME; Corrao S; Pallio G; Sterrantino C; Minutoli L; Saitta A; Vaccaro M; Cucinotta D
    J Clin Endocrinol Metab; 2014 May; 99(5):E746-53. PubMed ID: 24483158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers.
    Martínez-de Jesús FR; Morales-Guzmán M; Castañeda M; Pérez-Morales A; García-Alonso J; Mendiola-Segura I
    Arch Med Res; 1997; 28(1):95-9. PubMed ID: 9078595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical administration of a connexin43-based peptide augments healing of chronic neuropathic diabetic foot ulcers: A multicenter, randomized trial.
    Grek CL; Prasad GM; Viswanathan V; Armstrong DG; Gourdie RG; Ghatnekar GS
    Wound Repair Regen; 2015; 23(2):203-12. PubMed ID: 25703647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic diabetic foot ulcers with bemiparin: a randomized, triple-blind, placebo-controlled, clinical trial.
    Rullan M; Cerdà L; Frontera G; Masmiquel L; Llobera J
    Diabet Med; 2008 Sep; 25(9):1090-5. PubMed ID: 19183313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study.
    Rees RS; Robson MC; Smiell JM; Perry BH
    Wound Repair Regen; 1999; 7(3):141-7. PubMed ID: 10417749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical application of the bee hive protectant propolis is well tolerated and improves human diabetic foot ulcer healing in a prospective feasibility study.
    Henshaw FR; Bolton T; Nube V; Hood A; Veldhoen D; Pfrunder L; McKew GL; Macleod C; McLennan SV; Twigg SM
    J Diabetes Complications; 2014; 28(6):850-7. PubMed ID: 25239451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin peptide Chrysalin stimulates healing of diabetic foot ulcers in a placebo-controlled phase I/II study.
    Fife C; Mader JT; Stone J; Brill L; Satterfield K; Norfleet A; Zwernemann A; Ryaby JT; Carney DH
    Wound Repair Regen; 2007; 15(1):23-34. PubMed ID: 17244316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NorLeu3-A(1-7) stimulation of diabetic foot ulcer healing: results of a randomized, parallel-group, double-blind, placebo-controlled phase 2 clinical trial.
    Balingit PP; Armstrong DG; Reyzelman AM; Bolton L; Verco SJ; Rodgers KE; Nigh KA; diZerega GS
    Wound Repair Regen; 2012; 20(4):482-90. PubMed ID: 22672145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step autologous grafting using HYAFF scaffolds in treating difficult diabetic foot ulcers: results of a multicenter, randomized controlled clinical trial with long-term follow-up.
    Uccioli L; Giurato L; Ruotolo V; Ciavarella A; Grimaldi MS; Piaggesi A; Teobaldi I; Ricci L; Scionti L; Vermigli C; Seguro R; Mancini L; Ghirlanda G
    Int J Low Extrem Wounds; 2011 Jun; 10(2):80-5. PubMed ID: 21693443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of ulcer size on the wound radius reductions and healing times in neuropathic diabetic foot ulcers.
    Zimny S; Schatz H; Pfohl M
    Exp Clin Endocrinol Diabetes; 2004 Apr; 112(4):191-4. PubMed ID: 15127323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.